Reversible cerebral lesions associated with tiazofurin usage: MR demonstration

David J. Rippe, Mary K. Edwards, Jerome F. Schrodt, James R. Bognanno, Peter G. D’Amour, Orest B. Boyko

Research output: Contribution to journalArticle

17 Scopus citations


Tiazofurin is an experimental chemotherapeutic agent currently undergoing clinical evaluation. We report our results with magnetic resonance (MR) in demonstrating reversible cerebral abnormalities concurrent with the use of this drug. The abnormalities on MR were correlated with findings on CT as well as with cerebral angiography. The utility of MR in the evaluation of patients receiving this new agent is illustrated.

Original languageEnglish (US)
Pages (from-to)1078-1081
Number of pages4
JournalJournal of Computer Assisted Tomography
Issue number6
StatePublished - Jan 1 1988


  • Abnormalities
  • Brain
  • Complications
  • Drugs
  • Magnetic resonance imaging

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Fingerprint Dive into the research topics of 'Reversible cerebral lesions associated with tiazofurin usage: MR demonstration'. Together they form a unique fingerprint.

Cite this